Maria Raptis

Practice Areas

Maria Raptis represents clients in connection with antitrust aspects of mergers and acquisitions, litigation, counseling and criminal matters. She concentrates her practice on representing clients before the Federal Trade Commission (FTC) and Department of Justice. Ms. Raptis has advised clients in a broad range of strategic transactions across multiple industries, including health care and pharmaceuticals, technology, consumer products, entertainment and manufacturing. Her litigation experience includes defending clients in connection with class actions and multidistrict litigations challenging patent settlements, pricing and other business policies. Ms. Raptis also has represented clients in connection with allegations of price-fixing and other criminal charges.

Publications

Skadden Discusses DOJ Antitrust Enforcement Against Interlocking Directorates (The CLS Blue Sky Blog, December 7, 2022);

DOJ Antitrust Division Ramping Up Enforcement Efforts Against Interlocking Directorates (Skadden, November 23, 2022);

The Guide to Life Sciences (Merger Control: Substantive Issues) (Global Competition Review, 2022);

How Antitrust Regulators and the SEC Are Advancing the Wider Biden Agenda (Skadden Insights – June 2022);

Skadden Discusses What Regulatory Focus on Consolidation May Mean for Private Equity Buyers (The CLS Blue Sky Blog, May 3, 2022);

Regulatory Focus on Consolidation May Present Opportunities for Private Equity Buyers (Skadden Insights – April 2022);

FTC Sues To Block $40 Billion NVIDIA Acquisition of Arm, Reinforcing Aggressive Enforcement Agenda (The M&A Lawyer, December 20, 2021);

Antitrust Enforcement Takes a Sharp Left Turn (October 2021); Interlocking Boards: The Antitrust Risk You May Never Have Heard Of (Skadden, June 2021)

Education

Awards